Codelivery of Anti‐PD‐1 Antibody and Paclitaxel with Matrix Metalloproteinase and pH Dual‐Sensitive Micelles for Enhanced Tumor Chemoimmunotherapy-Reference-Cited by-同舟云学术

Codelivery of Anti‐PD‐1 Antibody and Paclitaxel with Matrix Metalloproteinase and pH Dual‐Sensitive Micelles for Enhanced Tumor Chemoimmunotherapy

Published:2020-01-28 Issue:7 Volume:16 Page:1906832
ISSN:1613-6810
Container-title:Small
language:en
Short-container-title:Small

Author:

Su Zhenwei¹,Xiao Zecong¹,Wang Yong²,Huang Jinsheng¹²,An Yongcheng³,Wang Xu⁴,Shuai Xintao¹^ORCID

Affiliation:

1. PCFM Lab of Ministry of EducationSchool of Materials Science and EngineeringSun Yat‐sen University Guangzhou 510275 P. R. China

2. College of Chemistry and Materials ScienceJinan University Guangzhou 510632 P. R. China

3. Department of Minimally Invasive Interventional Radiology and Laboratory of Interventional RadiologyThe Second Affiliated Hospital of Guangzhou Medical University Guangzhou 510275 P. R. China

4. Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics (Theranostics)School of PharmacyTianjin Medical University Tianjin 300070 P. R. China

Funder

National Natural Science Foundation of China

National Basic Research Program of China

Natural Science Foundation of Guangdong Province

Publisher

Wiley

Subject

Biomaterials,Biotechnology,General Materials Science,General Chemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/smll.201906832

Reference60 articles.

1. Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC